Mcf Advisors LLC Organon & Co. Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Mcf Advisors LLC holds 301 shares of OGN stock, worth $4,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares

301

Previous 319 5.64%

Holding current value

$4,445

Previous $6,000 16.67%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$18.65 - $23.03 $335 - $414	-18 Reduced 5.64%	301 $5,000
Q2 2024 Aug 05, 2024	SELL	$17.45 - $21.96 $1,204 - $1,515	-69 Reduced 17.78%	319 $6,000
Q1 2024 Apr 16, 2024	SELL	$13.78 - $18.8 $330 - $451	-24 Reduced 5.83%	388 $7,000
Q4 2023 Feb 01, 2024	BUY	$10.95 - $17.32 $21 - $34	2 Added 0.49%	412 $5,000
Q3 2023 Oct 19, 2023	BUY	$16.59 - $23.77 $16 - $23	1 Added 0.24%	410 $7,000
Q2 2023 Jul 24, 2023	SELL	$19.27 - $24.63 $2,871 - $3,669	-149 Reduced 26.7%	409 $8,000
Q1 2023 Apr 18, 2023	SELL	$21.42 - $32.08 $2,763 - $4,138	-129 Reduced 18.78%	558 $13,000
Q4 2022 Jan 31, 2023	SELL	$23.31 - $28.61 $2,447 - $3,004	-105 Reduced 13.26%	687 $19,000
Q3 2022 Nov 09, 2022	BUY	$23.4 - $34.25 $46 - $68	2 Added 0.25%	792 $19,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $1,108 - $1,361	-35 Reduced 4.24%	790 $27,000
Q1 2022 May 05, 2022	BUY	$30.45 - $39.36 $25,121 - $32,472	825 New	825 $28,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $25,602 - $33,157	-893 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $1,431 - $1,782	50 Added 5.93%	893 $29,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $23,983 - $32,034	843 New	843 $26,000

Others Institutions Holding OGN

# of Institutions

794

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account